These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7872342)

  • 61. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production.
    Ogawa T; Linz W; Stevenson M; Bruneau BG; Kuroski de Bold ML; Chen JH; Eid H; Schölkens BA; de Bold AJ
    Circulation; 1996 Jun; 93(11):2059-67. PubMed ID: 8640983
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.
    Nagaya N; Nishikimi T; Okano Y; Uematsu M; Satoh T; Kyotani S; Kuribayashi S; Hamada S; Kakishita M; Nakanishi N; Takamiya M; Kunieda T; Matsuo H; Kangawa K
    J Am Coll Cardiol; 1998 Jan; 31(1):202-8. PubMed ID: 9426041
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of hypertension with perindopril reduces plasma atrial natriuretic peptide levels, left ventricular mass, and improves echocardiographic parameters of diastolic function.
    Yalçin F; Aksoy FG; Muderrisoglu H; Sabah I; Garcia MJ; Thomas JD
    Clin Cardiol; 2000 Jun; 23(6):437-41. PubMed ID: 10875035
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.
    Motwani JG; McAlpine H; Kennedy N; Struthers AD
    Lancet; 1993 May; 341(8853):1109-13. PubMed ID: 8097802
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of cardio-ankle vascular index with brain natriuretic peptide levels in hypertension.
    Masugata H; Senda S; Inukai M; Murao K; Himoto T; Hosomi N; Murakami K; Noma T; Kohno M; Okada H; Goda F
    J Atheroscler Thromb; 2012; 19(3):255-62. PubMed ID: 22056595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy.
    Sato A; Saruta T
    J Int Med Res; 2001; 29(1):13-21. PubMed ID: 11277342
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T; Edelstein CL; Chapman AB; Johnson AM; Tison L; Gill EA; Brosnahan GM; Schrier RW
    Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy.
    Rizzoni D; Muiesan ML; Porteri E; Castellano M; Zulli R; Bettoni G; Salvetti M; Monteduro C; Agabiti-Rosei E
    J Hypertens; 1997 Feb; 15(2):197-204. PubMed ID: 9469796
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Insulin-like growth factor I and collagen type III synthesis in patients with essential hypertension and left ventricular hypertrophy.
    Diéz J; Laviades C
    J Hum Hypertens; 1994 Sep; 8 Suppl 1():S21-5. PubMed ID: 7807509
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension.
    Meng L; Ye XJ; Ding WH; Yang Y; Di BB; Liu L; Huo Y
    J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):643-7. PubMed ID: 21508845
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased plasma brain natriuretic peptide levels in DOCA-salt hypertensive rats: relation to blood pressure and cardiac concentration.
    Yokota N; Aburaya M; Yamamoto Y; Kato J; Kitamura K; Kida O; Eto T; Minamino N; Kangawa K; Matsuo H
    Biochem Biophys Res Commun; 1990 Dec; 173(2):632-8. PubMed ID: 2148083
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population.
    Luchner A; Burnett JC; Jougasaki M; Hense HW; Heid IM; Muders F; Riegger GA; Schunkert H
    J Hypertens; 2000 Aug; 18(8):1121-8. PubMed ID: 10954005
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension.
    Fogari R; Zoppi A; Mugellini A; Tettamanti F; Lusardi P; Corradi L
    Eur Heart J; 1995 Aug; 16(8):1120-5. PubMed ID: 8665975
    [TBL] [Abstract][Full Text] [Related]  

  • 74. B-type natriuretic peptide is related to left ventricular mass in hypertensive patients but not in athletes.
    Almeida S; Azevedo A; Castro A; Friões F; Freitas J; Ferreira A; Bettencourt P
    Cardiology; 2002; 98(3):113-5. PubMed ID: 12417808
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor on left ventricular mass and diastolic function in patients with essential hypertension.
    Sato A; Hayashi M; Saruta T
    Hypertens Res; 2002 Nov; 25(6):837-42. PubMed ID: 12484506
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Natriuretic peptides as indicators of cardiac remodeling in hypertensive patients.
    Magnusson M; Jovinge S; Rydberg E; Dahlöf B; Hall C; Nielsen OW; Grubb A; Willenheimer R
    Blood Press; 2009; 18(4):196-203. PubMed ID: 19562575
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [B-type natriuretic peptides and subclinical target organ damage in essential hypertensive patients].
    Peng XL; Lin ZP; Zhang RK; Zhang ZW
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2347-50. PubMed ID: 20965843
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension.
    Suzuki M; Yamamoto K; Watanabe S; Iwata T; Hamada M; Hiwada K
    Am J Med; 2000 Jun; 108(8):627-33. PubMed ID: 10856410
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension.
    Oki T; Fukuda N; Iuchi A; Tabata T; Sasaki M; Kawahara K; Ishimoto T; Tominaga T; Okushi H; Fujimoto T; Ito S
    J Card Fail; 1995 Dec; 1(5):365-70. PubMed ID: 12836711
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
    Díez J; Laviades C; Mayor G; Gil MJ; Monreal I
    Circulation; 1995 Mar; 91(5):1450-6. PubMed ID: 7867186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.